KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Synopsys (SNPS) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Synopsys (SNPS) over the last 17 years, with Q4 2025 value amounting to $27.3 million.

  • Synopsys' Asset Writedowns and Impairment rose 44359.59% to $27.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $50.9 million, marking a year-over-year increase of 15801.56%. This contributed to the annual value of $50.9 million for FY2025, which is 15801.56% up from last year.
  • Latest data reveals that Synopsys reported Asset Writedowns and Impairment of $27.3 million as of Q4 2025, which was up 44359.59% from $7.6 million recorded in Q3 2025.
  • Over the past 5 years, Synopsys' Asset Writedowns and Impairment peaked at $27.3 million during Q4 2025, and registered a low of -$9.8 million during Q2 2022.
  • Over the past 5 years, Synopsys' median Asset Writedowns and Impairment value was $5.0 million (recorded in 2024), while the average stood at $5.6 million.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first plummeted by 48049.73% in 2022, then soared by 66948.99% in 2023.
  • Over the past 5 years, Synopsys' Asset Writedowns and Impairment (Quarter) stood at $4.7 million in 2021, then plummeted by 77.9% to $1.0 million in 2022, then surged by 669.49% to $8.0 million in 2023, then plummeted by 37.11% to $5.0 million in 2024, then skyrocketed by 443.6% to $27.3 million in 2025.
  • Its last three reported values are $27.3 million in Q4 2025, $7.6 million for Q3 2025, and $6.0 million during Q2 2025.